Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.
Matsuo
H
H
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Nakamura
T
T
Shibayama
K
K
Motomura
M
M
Nagasato
K
K
Takeo
G
G
Tsujihata
M
M
Nagataki
S
S
D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007937:Leukapheresis; D008297:Male; D008875:Middle Aged; D015493:Paraparesis, Tropical Spastic / Q000188:drug therapy / Q000628:therapy*; D010956:Plasmapheresis; D011239:Prednisolone / Q000627:therapeutic use
D007370:Interferon Type I; D003520:Cyclophosphamide; D011239:Prednisolone